Table of Contents

1 Study Coverage

• 1.1 Bisphosphonate Drug Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Bisphosphonate Drug Market Size Growth Rate by Product
  • 1.4.2 Alendronate
  • 1.4.3 Risedronate
  • 1.4.4 Zoledronic acid
  • 1.4.5 Other Bisphosphonate Drug
• 1.5 Market by End User
  • 1.5.1 Global Bisphosphonate Drug Market Size Growth Rate by End User
  • 1.5.2 Postmenopausal osteoporosis
  • 1.5.3 Men with osteoporosis
  • 1.5.4 Paget’s disease
  • 1.5.5 Bone loss caused by cancer treatment
  • 1.5.6 Osteoporosis imperfecta in children
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Bisphosphonate Drug Market Size
  • 2.1.1 Global Bisphosphonate Drug Revenue 2014-2025
  • 2.1.2 Global Bisphosphonate Drug Sales 2014-2025
• 2.2 Bisphosphonate Drug Growth Rate by Regions
  • 2.2.1 Global Bisphosphonate Drug Sales by Regions
  • 2.2.2 Global Bisphosphonate Drug Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Bisphosphonate Drug Sales by Manufacturers
  • 3.1.1 Bisphosphonate Drug Sales by Manufacturers
  • 3.1.2 Bisphosphonate Drug Sales Market Share by Manufacturers
  • 3.1.3 Global Bisphosphonate Drug Market Concentration Ratio (CR5 and HHI)
• 3.2 Bisphosphonate Drug Revenue by Manufacturers
  • 3.2.1 Bisphosphonate Drug Revenue by Manufacturers (2014-2019)
  • 3.2.2 Bisphosphonate Drug Revenue Share by Manufacturers (2014-2019)
• 3.3 Bisphosphonate Drug Price by Manufacturers
• 3.4 Bisphosphonate Drug Manufacturing Base Distribution, Product Types
  • 3.4.1 Bisphosphonate Drug Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Bisphosphonate Drug Product Type
  • 3.4.3 Date of International Manufacturers Enter into Bisphosphonate Drug Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Bisphosphonate Drug Sales by Product
• 4.2 Global Bisphosphonate Drug Revenue by Product
• 4.3 Bisphosphonate Drug Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Bisphosphonate Drug Breakdown Data by End User

6 North America

• 6.1 North America Bisphosphonate Drug by Countries
  • 6.1.1 North America Bisphosphonate Drug Sales by Countries
  • 6.1.2 North America Bisphosphonate Drug Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Bisphosphonate Drug by Product
• 6.3 North America Bisphosphonate Drug by End User

7 Europe

• 7.1 Europe Bisphosphonate Drug by Countries
  • 7.1.1 Europe Bisphosphonate Drug Sales by Countries
  • 7.1.2 Europe Bisphosphonate Drug Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Bisphosphonate Drug by Product
• 7.3 Europe Bisphosphonate Drug by End User

8 Asia Pacific

• 8.1 Asia Pacific Bisphosphonate Drug by Countries
  • 8.1.1 Asia Pacific Bisphosphonate Drug Sales by Countries
  • 8.1.2 Asia Pacific Bisphosphonate Drug Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Bisphosphonate Drug by Product
• 8.3 Asia Pacific Bisphosphonate Drug by End User

9 Central & South America

• 9.1 Central & South America Bisphosphonate Drug by Countries
  • 9.1.1 Central & South America Bisphosphonate Drug Sales by Countries
  • 9.1.2 Central & South America Bisphosphonate Drug Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Bisphosphonate Drug by Product
• 9.3 Central & South America Bisphosphonate Drug by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Bisphosphonate Drug by Countries
  • 10.1.1 Middle East and Africa Bisphosphonate Drug Sales by Countries
  • 10.1.2 Middle East and Africa Bisphosphonate Drug Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Bisphosphonate Drug by Product
• 10.3 Middle East and Africa Bisphosphonate Drug by End User

11 Company Profiles

• 11.1 Merck
  • 11.1.1 Merck Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Merck Bisphosphonate Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Merck Bisphosphonate Drug Products Offered
  • 11.1.5 Merck Recent Development
• 11.2 Teva
  • 11.2.1 Teva Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Teva Bisphosphonate Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Teva Bisphosphonate Drug Products Offered
  • 11.2.5 Teva Recent Development
• 11.3 Mylan
  • 11.3.1 Mylan Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Mylan Bisphosphonate Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Mylan Bisphosphonate Drug Products Offered
  • 11.3.5 Mylan Recent Development
• 11.4 Apotex Corp
  • 11.4.1 Apotex Corp Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Apotex Corp Bisphosphonate Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Apotex Corp Bisphosphonate Drug Products Offered
  • 11.4.5 Apotex Corp Recent Development
• 11.5 Cobalt Pharmaceuticals
  • 11.5.1 Cobalt Pharmaceuticals Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Cobalt Pharmaceuticals Bisphosphonate Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Cobalt Pharmaceuticals Bisphosphonate Drug Products Offered
  • 11.5.5 Cobalt Pharmaceuticals Recent Development
• 11.6 Genentech
  • 11.6.1 Genentech Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Genentech Bisphosphonate Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Genentech Bisphosphonate Drug Products Offered
  • 11.6.5 Genentech Recent Development
• 11.7 Novartis Pharmaceuticals
  • 11.7.1 Novartis Pharmaceuticals Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Novartis Pharmaceuticals Bisphosphonate Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Novartis Pharmaceuticals Bisphosphonate Drug Products Offered
  • 11.7.5 Novartis Pharmaceuticals Recent Development
• 11.8 Sanofi-Aventis
  • 11.8.1 Sanofi-Aventis Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Sanofi-Aventis Bisphosphonate Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Sanofi-Aventis Bisphosphonate Drug Products Offered
  • 11.8.5 Sanofi-Aventis Recent Development

12 Future Forecast

• 12.1 Bisphosphonate Drug Market Forecast by Regions
  • 12.1.1 Global Bisphosphonate Drug Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Bisphosphonate Drug Revenue Forecast by Regions 2019-2025
• 12.2 Bisphosphonate Drug Market Forecast by Product
  • 12.2.1 Global Bisphosphonate Drug Sales Forecast by Product 2019-2025
  • 12.2.2 Global Bisphosphonate Drug Revenue Forecast by Product 2019-2025
• 12.3 Bisphosphonate Drug Market Forecast by End User
• 12.4 North America Bisphosphonate Drug Forecast
• 12.5 Europe Bisphosphonate Drug Forecast
• 12.6 Asia Pacific Bisphosphonate Drug Forecast
• 12.7 Central & South America Bisphosphonate Drug Forecast
• 12.8 Middle East and Africa Bisphosphonate Drug Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Bisphosphonate Drug Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Bisphosphonates are drugs that inhibit mineralization or resorption of the bone by blocking the action of osteoclasts. Bisphosphonates are enzyme-resistant analogues of pyrophosphate, which normally inhibits mineralization in the bone. Their effect is dose dependent and they reduce the turnover of bone by inhibiting recruitment and promoting apoptosis of osteoclasts. Bisphosphonates are used to treat postmenopausal and glucocorticoid induced osteoporosis, Paget's disease of bone and malignant hypercalcemia.
The global Bisphosphonate Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Bisphosphonate Drug market based on company, product type, end user and key regions.

This report studies the global market size of Bisphosphonate Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Bisphosphonate Drug in these regions.
This research report categorizes the global Bisphosphonate Drug market by top players/brands, region, type and end user. This report also studies the global Bisphosphonate Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck
Teva
Mylan
Apotex Corp
Cobalt Pharmaceuticals
Genentech
Novartis Pharmaceuticals
Sanofi-Aventis

Market size by Product
Alendronate
Risedronate
Zoledronic acid
Other Bisphosphonate Drug
Market size by End User
Postmenopausal osteoporosis
Men with osteoporosis
Paget’s disease
Bone loss caused by cancer treatment
Osteoporosis imperfecta in children

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Bisphosphonate Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Bisphosphonate Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Bisphosphonate Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Bisphosphonate Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Bisphosphonate Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Bisphosphonate Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.